Ainos, Inc. Secures $1.5M Funding via Convertible Notes
Ticker: AIMDW · Form: 8-K · Filed: May 6, 2024 · CIK: 1014763
| Field | Detail |
|---|---|
| Company | Ainos, INC. (AIMDW) |
| Form Type | 8-K |
| Filed Date | May 6, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $9,000,000, $4.50 |
| Sentiment | bullish |
Sentiment: bullish
Topics: financing, convertible-debt, warrants
Related Tickers: AIMD
TL;DR
Ainos just raised $1.5M from an accredited investor via convertible notes and warrants. Bullish for cash flow!
AI Summary
On May 3, 2024, Ainos, Inc. entered into a Material Definitive Agreement, specifically a Securities Purchase Agreement, with an accredited investor. This agreement involves the sale of approximately $1.5 million worth of convertible promissory notes and warrants. The company also announced the creation of a direct financial obligation related to this transaction.
Why It Matters
This funding infusion provides Ainos, Inc. with capital to advance its operations and potentially develop its pharmaceutical products, impacting its future growth and market position.
Risk Assessment
Risk Level: medium — The company is issuing convertible notes, which can dilute existing shareholders if converted, and the success of the funding depends on the company's ability to execute its business plan.
Key Numbers
- $1.5M — Funding Amount (Raised through convertible notes and warrants)
Key Players & Entities
- Ainos, Inc. (company) — Registrant
- May 3, 2024 (date) — Date of earliest event reported
- $1.5 million (dollar_amount) — Amount of funding
- Securities Purchase Agreement (agreement) — Material Definitive Agreement
FAQ
What is the interest rate on the convertible promissory notes?
The filing does not specify the interest rate on the convertible promissory notes.
What are the terms of the warrants issued?
The filing mentions warrants were issued but does not detail their specific terms, such as exercise price or expiration date.
Who is the accredited investor that purchased the securities?
The filing refers to 'an accredited investor' but does not disclose their specific identity.
What will Ainos, Inc. use the proceeds from this financing for?
The filing does not explicitly state the intended use of the proceeds from this financing.
When are the convertible promissory notes due?
The filing does not specify the maturity date of the convertible promissory notes.
Filing Stats: 895 words · 4 min read · ~3 pages · Grade level 9.6 · Accepted 2024-05-06 06:30:29
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share AIMD The Nasdaq Stock Mar
- $9,000,000 — in the aggregate principal amount of US$9,000,000. The note bears six percent compound in
- $4.50 — common stock at a conversion price of US$4.50 per share, subject to customary anti-di
Filing Documents
- form8-k.htm (8-K) — 47KB
- ex4-1.htm (EX-4.1) — 30KB
- ex4-2.htm (EX-4.2) — 46KB
- ex4-3.htm (EX-4.3) — 45KB
- ex10-1.htm (EX-10.1) — 157KB
- 0001493152-24-017831.txt ( ) — 580KB
- aimd-20240503.xsd (EX-101.SCH) — 4KB
- aimd-20240503_def.xml (EX-101.DEF) — 26KB
- aimd-20240503_lab.xml (EX-101.LAB) — 36KB
- aimd-20240503_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Ainos, Inc. Date: May 6, 2024 By: /s/ Chun-Hsien Tsai Name: Chun-Hsien Tsai Title: Chief Executive Officer